Special Issue Introduction
Special Issue Flyer
The progressive aging of the general population in many countries worldwide is a widely known and studied issue. Nowadays, a new category of people is born: the “oldest old”, namely persons aged more than 85 years, whose prevalence is increasing year by year. The scientific interest towards aging ranges from laboratory to clinical research; in the last years the attention to prevention topics has grown, in order to maintain older people not only alive, but healthy, fit, and with a preserved good quality of life.
Cardiovascular system is particularly affected by pathophysiological ad clinical challenges associated with aging: atherosclerosis, coronary heart disease, heart failure, cardiovascular autonomic changes, and orthostatic hypotension are only a few of the innumerable clinical phenotypes of a complex systemic cardiometabolic process, with many incompletely defined aspects.
The aim of this special issue is to offer a global audience of authors the possibility to shed light on some topics of great clinical impact, including but not limited to the mechanisms of cardiovascular aging and of target organ damage, the real need of treating cardiovascular risk factors in the elderly, and the metabolic effects of cardiovascular drugs in the oldest old.
Metabolism and Target Organ Damage
